Zoetis | ZTS - Assets


Zoetis reported $15.15B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
AbbVie USD 135.12B 1.35B Jun/2026
Align Technology USD 6.42B 103.41M Jun/2026
Bayer EUR 107.94B 3.4B Mar/2026
Bristol-Myers Squibb USD 87.63B 1.16B Jun/2026
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Coherus Biosciences USD 191.18M 74.84M Jun/2026
Dentsply International USD 5.23B 200M Mar/2026
Eli Lilly USD 142.28B 25.71B Jun/2026
Henry Schein USD 11.38B 77M Jun/2026
Idexx Laboratories USD 3.44B 56.84M Jun/2026
Illumina USD 6.65B 91M Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
J&J USD 201.06B 167M Jun/2026
Laboratory Of America USD 18.53B 554.8M Jun/2026
Merck USD 128.68B 8.18B Mar/2026
Neogen USD 3.35B 13M Mar/2026
Pacira USD 1.24B 35.44M Jun/2026
Perrigo USD 7.61B 373.8M Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026
Phibro Animal Health USD 1.45B 39.56M Mar/2026
Quest Diagnostics USD 16.94B 266M Jun/2026
Sanofi EUR 129.06B 1.04B Jun/2026
Sanofi EUR 128.02B 1.22B Mar/2026
Zoetis USD 15.15B 313M Mar/2026